Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
Laura S M KerkmeijerJaya ChandrasekharDeborah N KalkmanPier WoudstraIan B A MenownHarry SuryapranataPeter den HeijerAndrés IñiguezArnoud W J van 't HofAndrejs ErglisKarin E ArkenboutPhilippe MullerKarel T KochJan G TijssenMarcel A M BeijkRobbert J de WinterPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Percutaneous coronary intervention with the dual-therapy COMBO stent in unselected patient population shows low rates of TLF and ST to 5 years. Remarkably, no case of ST was noted beyond 3 years.